Powdery mildew is a tricky pathogen: The fungus can manipulate barley in a way that it is not only granted entry into the plant, but also gets the plant's cells to supply it with nutrients. A team of researchers at Technische ...
Biotechnology
Jul 12, 2011
0
0
A new chemical bonding process can add new functions to stainless steel and make it a more useful material for implanted biomedical devices. Developed by an interdisciplinary team at the University of Alberta and Canada's ...
Materials Science
Apr 27, 2011
0
0
A discovery by associate professor of chemistry and biochemistry Brian Baker and his research group at the University of Notre Dame reveals the importance of dynamic motion by proteins involved in the body's immune response. ...
Biochemistry
Jan 21, 2010
0
0
Researchers at Yale School of Medicine have found that exaggerated responses of the immune system explain why the elderly succumb to viral infections more readily than younger people. Published in the November 19 Cell Host ...
Cell & Microbiology
Nov 18, 2009
0
0
For cancer drug developers, finding an agent that kills tumor cells is only part of the equation. The drug must also spare healthy cells, and - ideally - its effects will be reversible, to cut short any potentially dangerous ...
Biochemistry
Aug 6, 2009
0
0
Cabbage looper caterpillars (Trichoplusia ni) are able to alter the expression of genes associated with metabolism, homeostasis and immunity in response to feeding on plants carrying bacteria. Research published in BioMed ...
Plants & Animals
May 7, 2009
0
0
Finding a way to bypass the molecular events involved in autoimmunity - where the body's immune system mounts a self-directed attack - could lead to new treatments for autoimmune disorders and chronic infections. A study ...
Cell & Microbiology
Mar 3, 2009
0
0
For the first time, a team of researchers at the University of Pennsylvania School of Veterinary Medicine have imaged in real time the body's immune response to a parasitic infection in the brain.
Jan 28, 2009
0
0
People who have a particular genetic variant are twice as likely to never get sick when they contract COVID-19, researchers said on Wednesday, offering the first potential explanation for the lucky group dubbed the "super ...
Biotechnology
Jul 19, 2023
0
3
Harlan and Chad Robins started Seattle-based Adaptive Biotechnologies 12 years ago to find a cure for cancer. Now, they have broadened their mission to take on COVID-19.
Biotechnology
Sep 22, 2021
0
7
